United States News All stories

Honeywell International (NASDAQ:HON) announced on Monday that it is reaffirming its full-year 2026 financial guidance as the company nears the final stages of its portfolio transformation.

Gamehaus Holdings (NASDAQ:GMHS) reported its unaudited financial results for the third quarter of fiscal year 2026, ended March 31, 2026.

American Battery Technology Company (NASDAQ:ABAT) announced today that it has successfully won its appeal with the U.S. Department of Energy (DOE) regarding the reinstatement of a competitive grant award.

Duluth Holdings (NASDAQ:DLTH) reported financial results for the first quarter of fiscal 2026, ended May 3, 2026, highlighting significant progress in operational efficiency despite a challenging retail environment.

Advanced Micro Devices (NASDAQ:AMD) announced plans to invest up to £2 billion in the United Kingdom over the next five years, a strategic move designed to accelerate AI innovation, scientific research, and technical workforce development.

Alvotech (NASDAQ:ALVO) announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio (vedolizumab) for intravenous administration.

LENZ Therapeutics (NASDAQ:LENZ) and Everest Medicines announced an agreement on June 8, 2026, transferring the rights to develop, manufacture, and commercialize LNZ100—marketed in the United States as VIZZ—within Greater China.

Nurix Therapeutics (NASDAQ:NRIX) announced on June 8, 2026, that it has entered into a global licensing and collaboration agreement with Roche to co-develop and co-commercialize bexobrutideg (NX-5948).

Global oil markets faced heightened volatility on Monday as investors reacted to an escalation in regional conflict.

Artiva Biotherapeutics (NASDAQ:ARTV) has shared encouraging clinical findings for its lead therapeutic candidate, AlloNK® (AB-101), during the European Alliance of Associations for Rheumatology (EULAR) 2026 congress.

Seaport Therapeutics (NASDAQ:SPTX) announced today positive data from the multiple-ascending dose (MAD) portion of its Phase 1 proof-of-concept clinical trial for GlyphAgo™ (SPT-320).

Aclarion (NASDAQ:ACON) announced that its Board of Directors has unanimously rejected an unsolicited, non-binding proposal from Echo Lake Capital to acquire the company at a price of $4 per share.

NextNRG (NASDAQ:NXXT) announced preliminary, unaudited financial results for May 2026, highlighting a 41% year-over-year increase in revenue to $9.3 million, compared to $6.6 million in the same month last year.

StealthGas (NASDAQ:GASS) reported a solid start to the 2026 fiscal year, with first-quarter net income reaching $15.9 million, up from $14.1 million during the same period a year earlier.

Edesa Biotech (NASDAQ:EDSA) announced favorable exploratory findings for its lead therapeutic candidate, paridiprubart, in patients suffering from acute kidney injury (AKI) and concurrent respiratory distress.

Consolidated Water (NASDAQ:CWCO), a provider of advanced water supply and treatment solutions, announced today that its board of directors has approved a quarterly cash dividend of $0.14 per share for the third quarter of 2026.

La Rosa Holdings (NASDAQ:LRHC) has released its financial results for the fiscal year ended December 31, 2025, reporting a 17% year-over-year increase in total revenue to $68.5 million.

Riyadh Air, Saudi Arabia's newest national carrier, has officially taken delivery of its first two factory-new Boeing 787-9 Dreamliners.

BioCardia (NASDAQ:BCDA) announced that minutes from a recent pre-submission (Q-Sub) meeting with the U.S. Food and Drug Administration (FDA) have provided a clearer regulatory roadmap for its CardiAMP Cell Therapy System.

Amneal Pharmaceuticals (NASDAQ:AMRX) has announced encouraging interim data from the Phase 4 ELEVATE-PD clinical trial, which evaluates the efficacy and safety of CREXONT (carbidopa and levodopa) extended-release capsules in patients living with Parkinson’s disease.

Hurco Companies (NASDAQ:HURC) announced its financial results for the second quarter of fiscal year 2026, showing significant momentum in booking activity and improved operational efficiency.

Argent Trust Company, acting as Trustee for the Sabine Royalty Trust (NYSE:SBR), has declared a cash distribution of $0.502990 per unit for June 2026.

Embraer (NYSE:EMBJ) and aircraft lessor Azorra announced an expansion of their strategic partnership on June 5, 2026, with a new firm order for 15 E195-E2 aircraft.

Seres Therapeutics (NASDAQ:MCRB) announced a series of strategic financial moves aimed at strengthening its liquidity position.